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Leukocyte-specific protein 1 (LSP1), an F-actin binding protein and a major downstream 
substrate of p38 mitogen-activated protein kinase as well as protein kinase C, has been 
reported to be important in leukocyte chemotaxis. Although its distribution has been 
thought to be restricted to leukocytes, herein we report that LSP1 is expressed in endothelium 
and is essential to permit neutrophil emigration. Using intravital microscopy to directly 
visualize leukocyte rolling, adhesion, and emigration in postcapillary venules in LSP1-deficient 
(
 
Lsp1
 
   
 
) mice, we found that LSP1 deficiency inhibits neutrophil extravasation in response 
to various cytokines (tumor necrosis factor-
 
 
 
 and interleukin-1
 
 
 
) and to neutrophil chemokine 
keratinocyte-derived chemokine in vivo. LSP1 deficiency did not affect leukocyte rolling or 
adhesion. Generation of 
 
Lsp1
 
   
 
 chimeric mice using bone marrow transplantation revealed 
that in mice with 
 
Lsp1
 
   
 
 endothelial cells and wild-type leukocytes, neutrophil transendothelial 
migration out of postcapillary venules is markedly restricted. In contrast, 
 
Lsp1
 
   
 
 neutrophils 
in wild-type mice were able to extravasate normally. Consistent with altered endothelial 
function was a reduction in vascular permeability to histamine in 
 
Lsp1
 
   
 
 animals. Western 
blot analysis and immunofluorescence microscopy examination confirmed the presence of 
LSP1 in wild-type but not in 
 
Lsp1
 
   
 
 mouse microvascular endothelial cells. Cultured human 
endothelial cells also stained positive for LSP1. Our results suggest that LSP1 expressed in 
endothelium regulates neutrophil transendothelial migration.
 
Lymphocyte-specific gene 1, found in both
mouse and humans, was initially thought to be
restricted to B cells, functional T cells, and thy-
mocytes (1, 2). However, more recently, it has
been documented in monocytes, macrophages,
and neutrophils and is now referred to as leuko-
cyte-specific protein 1 (LSP1; references 3–5).
LSP1 is an intracellular Ca
 
2
 
 
 
 and F-actin binding
protein (6–9). In its carboxyl-terminal region,
the molecule contains a high affinity F-actin
binding site which allows LSP1 to accumulate
within the microfilament rich cortical cytoskele-
ton. LSP1 has been shown to be a major sub-
strate of the mitogen-activated protein kinase
(MAPK)-activated protein (MAPKAP) kinase-2
in the p38 MAPK pathway (10). MAPKAP
kinase-2 and p38 MAPK were reported to be
essential for neutrophil motility and chemo-
taxis (11–13), suggesting that LSP1 might be
important in chemotaxis. However, it should
be noted that MAPKAP kinase-2 phosphory-
lates numerous other molecules, including heat
shock protein 25/27 (14), and so the impor-
tance of LSP1 after p38 MAPK activation re-
mains unclear. In addition, LSP1 has also been
shown to be a substrate for protein kinase C
(PKC; 15, 16), which is another molecule im-
plicated in numerous neutrophil functions (in-
cluding adhesion and chemotaxis; reference 17),
which raises the possibility that LSP1 may have
multiple roles in neutrophil recruitment.
Although recent in vitro studies using
LSP1-deficient (
 
Lsp1
 
   
 
) cells suggest that
LSP1 does contribute to the process of chemo-
taxis, as yet unexplained opposing results have
been observed. Jongstra-Bilen and colleagues
generated 
 
Lsp1
 
   
 
 mice and observed increased
chemotactic responses in 
 
Lsp1
 
   
 
 neutrophils
in vitro (18, 19). In direct contrast, Hannigan
et al. reported, in an in vitro study, reduced
chemotactic responses of 
 
Lsp1
 
   
 
 neutrophils,
which may be associated with discontinuous
primary actin-rich cortexes and large abnormal
membrane protrusions (20). Although both
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groups used keratinocyte-derived chemokine (KC) as a
chemoattractant, important differences in experimental condi-
tions between these in vitro experiments included different
substrates and different neutrophil populations (peritoneal elic-
ited or bone marrow neutrophils vs. peripheral blood neutro-
phils). Clearly, a systematic examination of neutrophil func-
tion in vivo in the presence and absence of LSP1 is warranted.
In vivo, neutrophil recruitment is a very complex event
that requires that neutrophils first tether to the endothelium,
and upon activation via chemokines, firmly adhere. This ap-
pears to lead to cross-talk between the adherent neutrophil
and the endothelium, whereby endothelial cells retract, al-
lowing neutrophils to migrate across the endothelium (21,
22) before chemotaxing toward the source of the injury
and/or infection. Recently, we reported that inhibition of
p38 MAPK activity dramatically limited neutrophil transmi-
gration across the endothelium and subsequent neutrophil
chemotaxis through the interstitium (13). However, whether
the p38 MAPK inhibitors were affecting the endothelium
and/or the neutrophils was unclear. This is not trivial as both
p38 MAPK and MAPKAP kinase-2 have been shown to
play a role in endothelial cytoskeletal rearrangements and in
increased endothelial permeability associated with hypoxic
or oxidative stress (23–25), as well as in TNF
 
 
 
 or VEGF stim-
ulation (26–28). However, no one to date has assessed the
possibility that LSP1 is found in endothelium.
During neutrophil recruitment, the endothelium is thought
to actively retract to allow neutrophils to transmigrate (21,
22, 29, 30). Because LSP1 is a major substrate for the p38
MAPK–MAPKAP kinase-2 signaling pathway and MAPK
appears to be important in both neutrophils and endothelium,
we tested the hypothesis that LSP1 is an important protein in
neutrophil extravasation in vivo as a result of endothelial
LSP1. Indeed, our data do not support a critical role for neu-
trophil LSP1 in extravasation in vivo; however, our results re-
veal that endothelium does have LSP1 and it plays an essential
role in transendothelial migration in chimeric mice where
LSP1 was selectively expressed in the endothelium.
 
RESULTS
LSP1 does not affect leukocyte rolling and adhesion, 
but is important for leukocyte emigration in response 
to TNF
 
 
 
 or IL-1
 
 
 
Table I summarizes the hemodynamics of the microvascula-
ture of 
 
Lsp1
 
   
 
 and WT mice 4 h after intrascrotal injection
of TNF
 
 
 
. The diameters of the chosen cremasteric venules
were similar between WT and 
 
Lsp1
 
   
 
 mice. There was no
apparent difference in shear rate, red blood cell velocity (Ta-
ble I), or calculated blood flow in these postcapillary venules
(not depicted). Similarly, during the induction of inflamma-
tion, there was a similar decrease in blood flow in postcapil-
lary venules in both WT and 
 
Lsp1
 
   
 
 mice. Therefore,
changes in leukocyte behavior described herein cannot be
attributed to differences in hemodynamic parameters. There
was a small but significant increase in circulating white blood
cells in 
 
Lsp1
 
   
 
 mice.
We treated WT and 
 
Lsp1
 
   
 
 mice intrascrotally with 0.5
 
 
 
g TNF
 
 
 
 and measured leukocyte rolling flux, rolling ve-
locity, and the number of adherent and emigrated leukocytes
in cremasteric venules 3.5, 4, and 4.5 h after cytokine injec-
tion. Fig. 1 A demonstrates that 
 
 
 
40
 
 
 
60 cells rolled per
minute in control preparations of both WT and 
 
Lsp1
 
   
 
mice. Exposure of the cremaster muscle microcirculation to
TNF
 
 
 
 induced very similar rolling flux in both WT and
 
Lsp1
 
   
 
 mice. The rolling velocity of leukocytes was 
 
 
 
80
 
 
 
m/s under control conditions in both sets of mice and a
very profound 80–90% decrease in rolling velocity was
noted in both WT and 
 
Lsp1
 
   
 
 mice after TNF
 
 
 
 adminis-
tration (Fig. 1 B). Fig. 1 C demonstrates a large increase in
leukocyte adhesion in postcapillary venules after TNF
 
 
 
treatment, a response that was again close to identical in WT
and 
 
Lsp1
 
   
 
 mice. However, a very significant difference in
leukocyte transendothelial migration was noted in WT and
 
Lsp1
 
   
 
 mice in response to TNF
 
 
 
 (Fig. 1 D). Although
 
 
 
40 cells emigrated out of vessels per field of view in WT
 
Table I.
 
Hemodynamic parameters in WT and 
 
Lsp1
 
   
 
 mice 
4 h after intrascrotal injection of TNF
 
 
 
 (0.5 
 
 
 
g, 
 
n
 
 = 3 
in each group)
 
Group
Venular
diameter V
 
RBC
 
Wall shear rate
WBC number
(
 
 
 
 10
 
6
 
 cells)
 
 
 
m mm/s s
 
 
 
1
 
WT 31 
 
 
 
 2.9 2.1 
 
 
 
 0.3 331.8 
 
 
 
 27.4 5.6 
 
 
 
 0.2
 
Lsp1
 
   
 
30 
 
 
 
 2.9 2.0 
 
 
 
 0.5 320.5 
 
 
 
 65.5 8.1 
 
 
 
 0.4
 
a
 
a
 
P 
 
 
 
 0.05 as compared with WBC number in WT mice.
WBC, white blood cell.
Figure 1. The flux of rolling leukocytes (A), rolling cell velocity (B), 
adherent (C), and emigrated (D) leukocytes in cremasteric venules of 
TNF -treated and untreated WT and Lsp1    mice. Leukocyte recruit-
ment was induced by intrascrotal injection of TNF  (0.5  g in 200  l 
saline) and the recruitment parameters determined in cremasteric venules 
from WT (WT control: n   4; WT   TNF : n   3) and Lsp1    mice (Lsp1    
control: n   6; Lsp1      TNF : n   3). *, P   0.05 and **, P   0.01, as 
compared with each untreated control group. 
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mice, only 15 cells emigrated in 
 
Lsp1
 
   
 
 mice (P 
 
 
 
 0.01). In
an additional group of WT mice, one fifth the concentration
of TNF
 
 
 
 was used. This caused fewer cells to adhere than in
 
Lsp1
 
   
 
 mice treated with the higher concentration of
TNF
 
 
 
, yet the emigration was still higher in WT mice than
that in 
 
Lsp1
 
   
 
 mice (unpublished data).
Previous papers have suggested that the mechanisms un-
derlying leukocyte emigration can be quite different for
TNF
 
  versus, for example, IL-1  (31, 32). To determine
whether the impaired emigration was limited to TNF , we
injected mice intrascrotally with an optimal dose (12.5 ng) of
IL-1  (31), and measured leukocyte rolling flux, rolling ve-
locity, and the number of adherent and emigrated leukocytes
in the tissues 3.5, 4, and 4.5 h after injection of cytokine. Af-
ter IL-1  local administration, leukocyte rolling flux was in-
creased in both WT and Lsp1    mice at least twofold
greater than untreated control mice (Fig. 2 A). Similar de-
crease in rolling velocity (Fig. 2 B) and increase in adhesion
(Fig. 2 C) to IL-1  was noted in WT and Lsp1    mice. Fig.
2 D demonstrates a profound 75% inhibition in leukocyte
transendothelial migration in Lsp1    mice (P   0.05).
Clearly, LSP1 plays a role in leukocyte emigration in re-
sponse to proinflammatory cytokines.
The impairment in Lsp1    mice could be due to an im-
pairment in cytokine signaling and subsequent synthesis of
chemokines or it could be an impairment in the emigration
process per se. Previous work has demonstrated that essen-
tially all of the emigrated cells at 4-h TNF  or IL-1  stimu-
lation are neutrophils (31, 33). Therefore, we examined re-
sponses of WT and Lsp1    neutrophils after activation of
their chemokine receptors to the neutrophil chemoattractant
KC in vivo.
LSP1 is essential for neutrophil emigration in response 
to the chemokine KC
We measured leukocyte rolling, adhesion, and transendothelial
migration upon slow release of the chemokine KC from an
agarose gel positioned 350  m from the observed cremasteric
postcapillary venule. Rolling was not affected by KC (Fig. 3
A), whereas neutrophils began adhering quite rapidly after the
KC-containing gel was placed on the cremaster preparation
(Fig. 3 B). However, there was no significant difference in the
rolling flux and adhesion response between WT and Lsp1   
mice. Fig. 3 C summarizes the number of emigrated neutro-
phils per field of view 60 min after local KC-containing gel
addition. In WT animals,  25 neutrophils could be seen out-
side the venule of study and all of the cells were migrating to-
ward the KC-containing gel (unpublished data). In contrast, in
the  Lsp1    mice, the transendothelial migration was even
more impaired in response to the chemokine KC at 60 min
than it was in response to cytokines. Less than four cells were
seen to migrate across the endothelium.
Figure 2. The flux of rolling leukocytes (A), rolling cell velocity (B), 
adherent (C), and emigrated (D) leukocytes in cremasteric venules of 
IL-1 –treated and untreated WT and Lsp1    mice. Leukocyte re-
cruitment was induced by intrascrotal injection of IL-1  (12.5 ng in 200  l 
saline) and the recruitment parameters determined in cremasteric venules 
from WT (WT control: n   4; WT   IL-1 : n   4) and Lsp1    mice 
(Lsp1    control: n   6; Lsp1      IL-1 : n   4). *, P   0.05 and 
**, P   0.01, as compared with each untreated control group.
Figure 3. The flux of rolling leukocytes (A), adherent leukocytes 
(B), and emigrated leukocytes (C) induced by KC in agarose gel 
placed 350  m from the observed cremasteric venule of WT (n   3) 
and Lsp1    (n   4) mice. **, P   0.01 as compared with time 0 (B) or 
with the WT control (C).ENDOTHELIAL LSP1 REGULATES LEUKOCYTE TRANSMIGRATION | Liu et al. 412
LSP1 is expressed in mouse and human endothelial cells
Because transendothelial migration is an active process of
both leukocytes and endothelium, we isolated leukocytes
from the peritoneal cavity in adult mice and primary endo-
thelial cells from the whole lung of 5–7-d-old WT and
Lsp1    mice. There was insufficient cremaster muscle tissue
to harvest sufficient numbers of endothelial cells. The large
majority of endothelium isolated from the lung is microvas-
cular in origin. RT-PCR revealed that both WT leukocytes
and WT endothelium, but not Lsp1    endothelium, had
mRNA for LSP1 (Fig. 4 A). By Western blotting and using
the original polyclonal anti-LSP1 serum, we observed that
WT but not Lsp1    mouse primary lung endothelial cells
expressed LSP1 protein (52-kD band) and both WT and
Lsp1    endothelial cells also showed an additional  78 kD
band (unpublished data). To obtain more specific antibodies
against mouse LSP1, we partially purified the polyclonal
anti-LSP1 serum, and by affinity absorption, we made anti-
NH2-terminal LSP1 and anti–COOH-terminal LSP1. Fig. 4
shows that both anti–NH2-terminal LSP1 (Fig. 4 B) and
anti–COOH-terminal LSP1 (Fig. 4 C) stained the 52-kD
LSP1 in WT but not in Lsp1    endothelial cells. The mo-
lecular mass of the mouse endothelial LSP1 was identical in
size to the leukocyte LSP1 ( 52 kD). This 52-kD band was
not observed in endothelial extracts from Lsp1    mice (Fig.
4, B and C). Moreover, the band was lost in WT endothelial
cells when the LPS1 antibody was preabsorbed against both
GST–LSP1 fusion proteins described in Materials and Meth-
ods (unpublished data).
There was an additional  78-kD band cross-reacting
only with anti–NH2-terminal LSP1 antibody expressed in
endothelial cells from both WT and Lsp1    mice, but not
in mouse leukocytes (Fig. 4 B). With two partially purified
antibodies against LSP1, we observed fluorescence staining
of WT and Lsp1    endothelial cells. Anti–NH2-terminal
LSP1 antibody stained much brighter on both WT and
Lsp1    endothelial cells than the anti–COOH-terminal
LSP1 staining, and the endothelial cells showed strong cyto-
skeletal staining with anti–NH2-terminal LSP1 antibody
(Fig. 5, top). Because this pattern was also seen in Lsp1   
mice, this cross-reactivity is likely with another cytoskeletal-
associated protein. Anti–COOH-terminal LSP1 antibody
specifically stained WT mouse endothelial cells but not
Lsp1    endothelial cells (Fig. 5, bottom). Interestingly, the
distribution of LSP1 in resting WT endothelial cells ap-
peared in the nuclei and very diffusely throughout the cyto-
plasm. Because LSP1 was stained weakly in the cytoplasm of
WT endothelial cells, it was difficult to determine whether
LSP1 associated with the endothelial cytoskeleton (Fig. 5,
bottom). In Lsp1    endothelial cells, the  78-kD protein
was still present, but the overall staining was diminished con-
sistent with the lack of LSP1 in Lsp1    endothelium.
To determine whether human endothelial cells express
LSP1, we double stained human umbilical vein endothelial
cells (HUVECs) with anti-LSP1 and anti–VE-cadherin or
phalloidin (F-actin). Fig. 6 demonstrates that, similar to
mouse endothelial cells, the VE-cadherin–expressing human
endothelial cells also express LSP1. Although the majority of
LSP1 staining was found in the nucleus, LSP1 staining in the
cytoplasm was weak but detectable (Fig. 6 A). Isotype con-
trol IgG and secondary Ab alone did not show any signifi-
cant fluorescence in the nucleus or the cytoplasm (not de-
picted and Fig. 6 D, respectively). To better detect the LSP1
staining pattern that was relatively weak in the cytoplasm
compared with the nuclear staining, we enhanced the fluo-
rescence signals of the dual-labeled LSP1 and phalloidin im-
Figure 4. LSP1 expression in mouse primary lung endothelial cells. 
(A) RT-PCR analysis of LSP1 mRNA was performed using total RNA extracted 
from mouse leukocytes and primary lung endothelial cells. (lane M) DNA 
molecular weight markers (Invitrogen) and (lanes 1–3) RT-PCR products 
from WT leukocyte RNA extracts (lane 1), Lsp1    endothelial RNA extracts 
(lane 2), and WT endothelial RNA extracts (lane 3). (B and C) Immunoblotting 
was performed with anti–NH2-terminal mouse LSP1 (B) and anti–COOH-
terminal mouse LSP1 (C) antibodies and with cell extracts as described in 
Materials and Methods. Cell lysates from 4 8   104 leukocytes were 
loaded in lanes 1 and 2, and 2   104 endothelial cells in lanes 3 and 4. 
Equal protein extracts were loaded in B and C. The protein concentrations 
in anti–NH2-terminal LSP1 and anti–COOH-terminal LSP1 solutions used 
for both blottings were 20  g/ml. (lane 1) Protein extracts of leukocytes 
from WT mice; (lane 2) protein extracts of leukocytes from Lsp1    mice; 
(lane 3) protein extracts of lung endothelial cells from WT mice; and (lane 4) 
protein extracts of lung endothelial cells from Lsp1    mice. The numbers 
to the left are molecular sizes (BenchMark prestained protein ladder; In-
vitrogen) in kilodaltons. Similar results were observed in three experiments 
with three batches of endothelial cell isolation.
Figure 5. Immunofluorescence staining pattern of cultured mouse 
lung endothelial cells with anti–NH2-terminal LSP1 and anti–COOH-
terminal LSP1. WT (left) and Lsp1    (right) mouse lung endothelial cells 
of passage 1 at subconfluence on glass coverslips were stained with anti–
NH2-terminal LSP1 (top) or anti–COOH-terminal LSP1 (bottom), respec-
tively, as described in Materials and Methods. Magnification, 200.JEM VOL. 201, February 7, 2005 413
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ages (via increasing the contrast; Fig. 6, E and F). The cyto-
plasmic LSP1 appeared to be distributed throughout the
cytoplasm, with some of the cytoplasmic LSP1 overlapping
with F-actin (Fig. 6, E and F). Although F-actin formed
clear finger-like projections characteristic of cytoskeleton
(Fig. 6 F), a significant amount of LSP1 was diffuse and not
always associated with these cytoskeletal structures (Fig. 6 E).
These results suggest the following: (a) the majority of endo-
thelial LSP1 is nuclear, (b) LSP1 distributes throughout the
endothelial cytoplasm, and (c) some endothelial cytoplasmic
LSP1 remains associated with F-actin or at least localizes ex-
tremely proximate to the endothelial cytoskeleton.
Endothelial LSP1 regulates leukocyte 
transendothelial migration
The surprising discovery of LSP1 in endothelium led us to
ask whether the protein had any function in the dramatic re-
duction in leukocyte transendothelial migration in Lsp1   
mice. We made chimeric mice that lacked LSP1 only in the
leukocytes. We also made chimeric mice where the Lsp1   
mice received a BM transplant from WT mice. These mice
lack LSP1 in endothelium. Upon TNF  local administra-
tion, both types of chimeric mice demonstrated similar re-
sponsiveness in leukocyte rolling flux (not depicted), rolling
velocity (not depicted), and adhesion (Fig. 7 A) in cremas-
teric venules. Surprisingly, chimeric mice that lacked LSP1
only in their leukocytes emigrated as effectively across the
vasculature as WT mice in response to TNF  injection, sug-
gesting that the impaired transendothelial emigration was
unrelated to leukocyte-derived LSP1 (Fig. 7 B). However,
WT leukocytes reconstituted in Lsp1    mice (i.e., lacking
LSP1 in endothelium) had difficulties in migrating through
the Lsp1    venules and into the tissue (P   0.01, as com-
pared with the reversed chimeric mice). Fig. 7 (C and D)
demonstrates that WT mice receiving WT BM behaved just
like the WT mice in Fig. 1 and Lsp1    mice receiving
Lsp1    BM behaved like Lsp1    mice in Fig. 1.
In a second series of experiments, we tested responses to
KC in the chimeric mice. Both sets of chimeric mice dem-
onstrated similar responsiveness in the leukocyte rolling flux
(not depicted), rolling velocity (not depicted), and adhesion
(Fig. 8 A) upon placement of the KC-containing gel onto
the muscle microvasculature. Again, chimeric mice that
lacked LSP1 only in their leukocytes emigrated as effectively
across the vasculature as WT mice (Fig. 8 B) in response to
KC administration. In contrast, WT leukocytes reconstituted
in Lsp1    mice (i.e., lacking LSP1 in endothelium) did not
display significant transendothelial migration (Fig. 8 B).
LSP1 is important in histamine-stimulated permeability 
increases in postcapillary venules
This is the first demonstration of LSP1 in endothelium and,
more importantly, the first demonstration of a functional
role for endothelial LSP1 in regulating leukocyte emigration.
Although the mechanism by which Lsp1    endothelium re-
stricts leukocyte recruitment is unclear, it is clear that LSP1 is
an F-actin binding protein and involved in cytoskeletal
changes in leukocytes (7, 8, 19). A very likely possibility is
that the Lsp1    endothelium did not actively retract to per-
mit leukocyte transendothelial migration. Therefore, we
Figure 6. Immunofluorescence localization of LSP1 in cultured 
human endothelial cells. HUVECs cultured on coverslips were double 
stained for LSP1 (red; A, C, E, and F) and VE-cadherin (green; B and C). 
(B–D) Cells were also counterstained for DAPI (blue). (C) The overlaid 
image of A and B. (D) Secondary Ab alone (Texas red) with DAPI staining. 
(E) The enhanced image (by increasing the contrast) of LSP1 staining pattern. 
(F) The enhanced image of LSP1 (from E) overlaid with phalloidin (green). 
Magnification, 400.
Figure 7. The number of adherent (A and C) and emigrated (B and 
D) leukocytes in a cremasteric venule of TNF -treated chimeric mice. 
WT and Lsp1    mice were reconstituted with Lsp1    and WT leukocytes, 
and indicated as Lsp1   →WT and WT→Lsp1   , respectively (A and B, 
n   3). WT and Lsp1    mice were also reconstituted with WT and Lsp1    
leukocytes, and indicated as WT→WT and Lsp1   →Lsp1   , respectively 
(C and D, n   3 4). Leukocyte recruitment was induced by intrascrotal 
injection of TNF  (0.5  g in 200  l saline) and the recruitment parameters 
determined in cremasteric venules from these chimeric mice. **, P   0.01 
as compared with the group of Lsp1   →WT mice at 4 h. *, P   0.05 as 
compared with the group of WT→WT mice at 4 h.ENDOTHELIAL LSP1 REGULATES LEUKOCYTE TRANSMIGRATION | Liu et al. 414
measured permeability responses in the postcapillary venules
in the control WT and Lsp1    mice. We chose histamine, a
stimulus that did not induce neutrophil emigration per se, to
avoid complications associated with neutrophils emigrating
in WT but not in Lsp1    mice. In each case, more FITC-
albumin leaked into the interstitium in WT than in Lsp1   
mice. Fig. 9 shows that at 1, 10, 30, and 60 min after 0.1 mM
histamine superfusion, the permeability index in venules of
WT mice was significantly higher than in venules of Lsp1   
mice (P   0.05). Thus, the results indicated that LSP1 has a
functional role in regulating the stimulated permeability
changes in postcapillary venules.
LSP1 deficiency does not decrease all forms 
of leukocyte recruitment
When we administered IL-1  to the peritoneal cavities of
WT and Lsp1    mice, there was very significant neutrophil
recruitment in both strains of mice. In fact, the total leuko-
cytes recovered from the peritoneal lavage were slightly
higher in Lsp1    mice than in WT mice (at 4 h, 11.1  
106   1.2   106 [n   5] cells in Lsp1    mice vs. 8.0  
106   0.7   106 [n   5] cells in WT mice; P   0.05), con-
sistent with previously published results (18).
DISCUSSION
In this paper, we have demonstrated that LSP1 appears to be
an essential intracellular molecule involved in the crucial
event of transendothelial migration that permits leukocytes
to be recruited to sites of inflammation. Neutrophil transen-
dothelial migration across postcapillary venules was clearly
impaired in vivo in Lsp1    mice when compared with WT
littermates. Not all leukocyte functions were inhibited inas-
much as rolling and adhesion within the vasculature (selec-
tin- and integrin-dependent events, respectively) were not
altered in Lsp1 /  mice. The impaired recruitment appeared
to occur regardless of whether an exogenous chemokine was
introduced or whether endogenous chemokines were pro-
duced by the local administration of TNF  or IL-1 . Until
now, LSP1 has been considered to be leukocyte specific;
however, we report herein that this F-actin binding protein
is also located in microvascular endothelium and functions to
permit neutrophil transendothelial migration, suggesting for
the first time both a new cellular source of LSP1 and a new
critical functional role for LSP1 in endothelium.
Although previous findings of altered neutrophil recruit-
ment in Lsp1    mice were considered to exclusively reflect
an alteration in neutrophil function per se (18–20), in this pa-
per, we provide evidence that endothelial LSP1 also contrib-
utes to the neutrophil recruitment. First, we demonstrated
that LSP1 was located in endothelium. The protein was the
same size as leukocyte LSP1 and was absent in Lsp1    mice.
Second, chimeric mice were generated that had WT leuko-
cytes and Lsp1    endothelium to delineate the importance
of endothelial LSP1. The results clearly demonstrated that
WT neutrophils had a profound inability to transmigrate
across Lsp1    endothelium. In contrast, Lsp1    neutrophils
migrated across WT endothelium with no impairment. In
addition, we report that Lsp1    endothelium was less re-
sponsive to histamine, a molecule known to activate the en-
dothelial cytoskeleton and induce endothelial retraction.
There is a growing body of evidence that endothelial
cells actively contribute to leukocyte transendothelial migra-
tion, not only by presenting adhesion molecules including
PECAM-1, CD99, and JAM-1, but also by actively retract-
ing and forming gaps upon leukocyte adhesion to the endo-
thelial cells and providing leukocytes a passage of lesser resis-
tance (21, 22, 29, 34, 35). Endothelial cell to cell adherens
junctions contain VE-cadherin, which links to different in-
tracellular proteins including  -catenin,   -catenin (plako-
globin), and p120; the former two connect to actin cytoskel-
eton through the binding to  -catenin (36, 37). The
retraction process has been shown in vitro and in vivo to in-
volve cytoskeletal rearrangement within the endothelium,
leading to the disengagement of catenins and VE-cadherins
and to the increase in endothelial permeability (38, 39); this
retraction can be triggered by both inflammatory mediators,
such as histamine, as well as by the direct process of leuko-
cyte adhesion (21, 22, 29, 34–37, 40). Disruption of endo-
thelial microfilaments significantly reduced leukocyte trans-
migration (41, 42). Although the signaling events leading to
the retraction of the endothelium upstream of the cytoskele-
Figure 8. The number of adherent (A) and emigrated (B) leuko-
cytes induced by KC in an agarose gel placed 350  m from the ob-
served cremasteric venule of chimeric mice. WT and Lsp1    mice were 
reconstituted with Lsp1    leukocytes and WT leukocytes, and indicated as 
Lsp1   →WT (n   5) and WT→Lsp1    (n   4), respectively. *, P   0.05 
and **, P   0.01, as compared with time 0 in A, or with the data of the WT 
mice reconstituted with Lsp1    leukocytes in B.
Figure 9. Microvascular permeability changes in cremasteric 
venules of WT (n   4) and Lsp1    mice (n   7) upon histamine 
superfusion. Measurements were taken before (time 0) and after 0.1 mM 
histamine superfusion of the cremaster muscle preparation. *, P   0.05 and 
**, P   0.01, as compared with the Lsp1    mice at the same time points.JEM VOL. 201, February 7, 2005 415
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ton are not entirely clear, the prevailing view at this stage is
that leukocytes engage surface molecules on the endothe-
lium that activate intracellular signaling events, including in-
creased intracellular Ca2  and activation of PKC and/or
myosin light chain kinase, leading to active retraction of en-
dothelium (21, 29, 43, 44). Because LSP1 has actin-binding
sites (8, 9), has been shown to play a role in adhesion-depen-
dent polarization (19), and is associated with the cytoplasmic
face of the plasma membrane (6), we propose that disruption
of LSP1 perturbs the ability of endothelium to retract and,
thus, decreases the histamine-induced permeability response
of the endothelium and neutrophil extravasation observed in
this paper. However, whether LSP1 simply functions up-
stream of the cytoskeletal changes or physically binds cyto-
skeleton remains unclear from our immunofluorescence data.
It should be noted that overexpression of LSP1 in endothe-
lium (via transfection) revealed significant cytoskeletal asso-
ciation (unpublished data).
It is well appreciated that, in leukocytes, LSP1 is one of
several key substrates of MAPKAP kinase-2 and the latter is
the direct target of p38 MAPK (10, 45). Several in vitro
studies have revealed that both p38 MAPK and MAPKAP
kinase-2 are important intracellular signaling molecules in
the induction of chemotaxis (11–13). Recently, we have re-
ported that inhibition of p38 MAPK in vivo resulted in both
an impairment in transendothelial migration and neutrophil
chemotaxis in response to the chemokine KC (13). In con-
trast, inhibition of p38 MAPK in vitro in human endothe-
lium did not impair recruitment in response to the cytokine
TNF  (46). In this paper, lack of LSP1 caused impaired em-
igration in response to both TNF  and KC. This clearly
suggests that the LSP1 deficiency extends well beyond the
role of substrate for p38 MAPK. Indeed, it has been reported
that LSP1 is also a major substrate for PKC (15, 16), a mole-
cule known to regulate endothelial retraction. An alternative
explanation is that the p38 MAPK inhibitors were less effec-
tive than LSP1 deficiency. The p38 MAPK inhibitors used
previously in this regard are known to specifically inhibit the
p38  and p38  isoform, but not the p38  and p38  iso-
forms. Because endothelium can express p38 ,  ,  , and  
(45), if LSP1 is downstream of each of these p38 isoforms,
then this may explain the additional inhibition seen in Lsp1   
mice versus p38 inhibitors.
The nonlethal phenotype of Lsp1    mice permitted ma-
nipulations that resolved the importance of this molecule in
different cell types. Indeed, if the LSP1 pathway is critical
within neutrophils for transendothelial migration, then, re-
moval of LSP1 only in leukocytes by generating LSP1 chi-
meric mice should have still resulted in an inability of Lsp1   
neutrophils to emigrate out of WT vasculature. Surpris-
ingly, BM transplantation of Lsp1    leukocytes into WT
mice restored normal transendothelial migration, suggesting
that the lack of neutrophil LSP1 was not responsible for the
impairment of transendothelial migration in Lsp1    mice.
Alternative explanations included the possibilities that the ir-
radiation process in some nonspecific manner altered the
transendothelial migration phenotype and that the irradiated
mice now had an enhanced responsiveness to chemokines.
However, our data from the reversed BM chimeras, in
which WT neutrophils failed to emigrate out of Lsp1    vas-
culature, refute these alternative explanations and support
the view that neutrophil transendothelial migration is depen-
dent on a nonleukocyte source of LSP1.
The impaired neutrophil recruitment due to LSP1 defi-
ciency in our study in muscle appeared to be either stimulus
or site specific as the work by Jongstra-Bilen and colleagues
clearly revealed the opposite response (i.e., enhanced recruit-
ment of leukocytes into the peritoneal cavity in response to
thioglycolate; reference 18). We found that, whereas the re-
cruitment of Lsp1    neutrophils was decreased in cremaster
muscle upon IL-1  local administration, the recruitment of
Lsp1    leukocytes into peritoneal cavity was not impaired
(but increased) after IL-1  i.p. injection. Although Lsp1   
neutrophils emigrated less into muscle in response to TNF ,
we also found that there was no apparent difference in the re-
cruitment of Lsp1    and WT leukocytes into peritoneal cav-
ity upon TNF  i.p. administration (unpublished data). These
results argue against stimulus specificity and support the no-
tion that structural or physiological differences of the organ
microvasculatures dictate organ-specific mechanisms of neu-
trophil recruitment (47).
This is the first documentation of a functional role for
LSP1 in endothelium. Some LSP1 could be detected associ-
ated with the cytoskeleton; however, the amount was quite
low. It may be that the protein only binds the cytoskeleton
after leukocyte binding to the endothelium, or perhaps un-
der flow conditions when the endothelium is under constant
state of shear force. In addition, under stimulating conditions
with a permeabilizing agent, perhaps the movement of LSP1
to cytoskeleton might be observed. Future studies will need
to examine under what conditions and how LSP1 interacts
with the actin cytoskeleton in endothelium. We will also
need to determine whether the recently described function
of LSP1 as a cytoskeletal ERK/MAP kinase pathway target-
ing protein (48) plays a role in its function as an endothelial
gatekeeper of leukocyte transendothelial migration.
MATERIALS AND METHODS
Animals. 129/SvJ WT mice were purchased from The Jackson Labora-
tory. Lsp1    mice on the 129/SvJ background were generated by homolo-
gous recombination by Jongstra-Bilen and colleagues as described previ-
ously (18) and transferred to the University of Calgary Health Sciences
Centre. Mice of these two genotypes were bred in the University Animal
Centre to obtain age- and sex-matched controls. The mice between 8 and
16 wk of age were used in experiments except for the mice used for isola-
tion of mouse endothelial cells (5–7 d old). TIE2-GFP mice were also pur-
chased from The Jackson Laboratory. All animal protocols were approved
by the Animal Care Committee of the University of Calgary and met the
standards of the Canadian Association of Animal Care. All animals were
kept in specific pathogen-free conditions.
Two types of BM chimeric mice were generated following the stan-
dard protocols in our laboratory (33). In brief, BM was isolated from 6–8-
wk-old donor mice killed by spinal cord displacement. The BM cell sus-
pensions (8   106 cells) from donor Lsp1    and 129/SvJ WT mice were
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Before BM cell injection, recipients were irradiated with two doses of 5 Gy
 -ray (Gammacell, 137Cs  -irradiation source) with a 3-h interval between
the two irradiations. These chimeric mice were housed in specific patho-
gen-free facilities for 6–8 wk to allow full humoral reconstitution before use
in experiments. Initial experiments confirmed that  99% of leukocytes
were from donor mice (33). Two additional control groups of mice (WT
into WT and Lsp1    into Lsp1   ) went through an identical protocol to
ensure that the transplant procedure did not cause any untoward effects.
Intravital microscopy. Male mice were anesthetized with an i.p. injec-
tion of a mixture of 10 mg/kg xylazine (Animal Health; Bayer Inc.) and 200
mg/kg ketamine hydrochloride (Rogar/STB Inc.). For all protocols, the left
jugular vein was cannulated to administer additional anesthetic or drugs
when necessary. The mouse cremaster muscle preparation was used to study
the behavior of leukocytes in the microcirculation and adjacent connective
tissue as described previously (49). In brief, an incision was made in the scro-
tal skin to expose the left cremaster muscle, which was then carefully dis-
sected free of the associated fascia. The cremaster muscle was cut longitudi-
nally with a cautery. The testicle and the epididymis were separated from the
underlying muscle and were moved into the abdominal cavity. The muscle
was held flat on an optically clear viewing pedestal and was secured along the
edges with 4–0 suture. The exposed tissue was superfused with 37 C
warmed bicarbonate-buffered saline, pH 7.4. An intravital microscope (Axi-
olskip; Carl Zeiss MicroImaging, Inc.) with a  25 objective lens (Weltzlar
L25/0.35; E. Leitz Inc.), and a  10 eyepiece was used to examine the cre-
masteric microcirculation. A video camera (5100 HS; Panasonic) was used to
project the images onto a monitor, and the images were recorded for play-
back analysis using a videocassette recorder.
Single unbranched cremasteric venules (25–40  m in diameter) were
selected, and to minimize variability, the same section of cremasteric venule
was observed throughout the experiment. The number of rolling, adherent,
and emigrated leukocytes was determined offline during video playback
analysis. Rolling leukocytes were defined as those cells moving at a velocity
less than that of erythrocytes within a given vessel. The flux of rolling cells
was measured as the number of rolling leukocytes passing by a given point
in the venule per minute. Leukocyte rolling velocity was measured for the
first 20 leukocytes entering the field of view at the time of recording and
calculated from the time required for a leukocyte to roll along a 100- m
length of venule. A leukocyte was considered to be adherent if it remained
stationary for at least 30 s, and total leukocyte adhesion was quantified as the
number of adherent cells within a 100- m length of venule in 5 min. Leu-
kocyte emigration was defined as the number of cells in the extravascular
space within a 200   300- m area (0.06 mm2), adjacent to the observed
venule. More than 90% of these emigrated cells were neutrophils (13, 31).
Only cells adjacent to and clearly outside the vessel under study were
counted as emigrated.
Induction of leukocyte recruitment in cremaster muscle. To deter-
mine whether emigration was impaired in response to cytokines, recombi-
nant mouse TNF  (0.5 or 0.1  g; R&D Systems) or IL-1  (12.5 ng; BD
Biosciences) in 200  l of saline was injected intrascrotally into Lsp1   ,
129/SvJ WT, or chimeric mice. The leukocyte rolling flux, rolling velocity,
adherence, and emigration were measured in the cremasteric venule at 3.5,
4, and 4.5 h after the injection.
To induce neutrophil recruitment independent of cytokines, an agarose
gel containing KC (CXCL1; R&D Systems) was used (13, 50). The agarose
gel was prepared by adding 10 ml of 2   HBSS to a boiling concentrated
agarose solution (4% in 10 ml of distilled water). A 100- l aliquot of this
solution was removed, and KC was added to this aliquot and mixed to
achieve a final concentration of 0.5  M. To enable visualization of the gel
on the cremaster muscle, a small amount of India ink was added to each
preparation. A 1-mm3 piece of the mixture (KC-containing gel) was
punched out using the tip of a Pasteur pipette. This piece of KC-containing
gel was carefully placed on the surface of the cremaster in a preselected area
350  m (two monitor screens wide) from a postcapillary venule. The gel
was held in place using a 22   22-mm glass coverslip, and the tissue was su-
perfused beneath the coverslip at a slow rate (0.35 ml/min) to create a che-
motactic gradient that permitted emigration. The image was recorded for
90 min: 30 min for control without gel and 60 min with KC-containing
gel. In control experiments, only the gel (without KC addition) was placed
on the surface of the cremaster muscle.
Microvascular permeability measurement. The degree of vascular al-
bumin leakage from cremasteric venules of Lsp1    and control 129/SvJ
mice was quantified as described previously (51). In brief, 25 mg/kg FITC-
labeled BSA (Sigma-Aldrich) was administered to the mice i.v. at the start of
the experiment, and FITC-derived fluorescence (excitation wavelength,
450–490 nm; emission wavelength, 520 nm) was detected using a silicon-
intensified charge-coupled device camera (model C-2400-80; Hamamatsu
Photonics). Image analysis software (Optimas; Bioscan Inc.) was used to de-
termine the intensity of FITC-albumin–derived fluorescence within the lu-
men of the venule and in the adjacent perivascular tissue. Background was
defined as the fluorescence intensity before FITC-albumin administration.
The exposed cremaster muscle was superfused with 0.1 mM histamine di-
hydrochloride (Sigma-Aldrich) in 37 C warmed bicarbonate-buffered sa-
line. The index of vascular albumin leakage (permeability index) at different
time points after histamine superfusion was determined according to the
following ratio expressed as a percentage: (mean interstitial intensity  
background)/(venular intensity   background) (51).
Harvesting endothelial cells and leukocytes. Acute mouse peritonitis
was induced to obtain emigrated leukocytes from Lsp1    and control 129/
SvJ WT mice. 3 h after an i.p. injection of 1% oyster glycogen (in 1 ml sa-
line; Sigma-Aldrich), leukocytes were lavaged from the peritoneum and
prepared for Western blotting (see the next paragraph). Mouse primary lung
endothelial cells were isolated from 5–7-d-old Lsp1    and control 129/SvJ
WT mice, and were cultured according to the protocols described previ-
ously (52). Using this protocol with TIE2-GFP mice and flow cytometry,
we verified that  93–98% of the isolated cells were GFP positive, confirm-
ing that the majority of the purified cells were of endothelial cell origin
(53). Freshly isolated mouse endothelial cells were cultured in microvascular
endothelial cell medium-2 (Clonetics EGM-2MV BulletKit; Cambrex Bio
Science) in 35-mm Petri dishes precoated with 20  g/ml mouse laminin
(Upstate Biotechnology). After reaching confluence in 5–6 d, the cells were
either used for Western blotting or trypsinized and subcultured on laminin-
coated 22   22-mm glass coverslips (at 30,000 cells/coverslip) contained in
35-mm Petri dishes.
Western blot and RT-PCR analysis. The polyclonal anti-LSP1 serum
was made in rabbits against mouse recombinant LSP1 protein (6). Although,
in leukocytes, the anti-LSP1 serum detected a single band at the appropriate
size for LSP1, a second band of  78 kD was detected in endothelium. To
remove this reactivity, the GST-LSP1 fusion proteins containing LSP1 resi-
dues 1–178 or 179–330 were constructed, subcloned, and expressed in Esch-
erichia coli BL21 (DE3) cells as described previously (54). These two fusion
proteins were allowed to conjugate agarose-glutathione beads and were
packed into separate glass columns. The polyclonal anti-LSP1 serum was
flowed at a rate of  0.15 ml/min (at 4 C) through the different columns
containing at least 10-fold molar excess fusion proteins (residues 1–178 or
179–330). The flow-through fractions containing  1.5 mg/ml protein
concentrations, which were the anti–COOH-terminal LSP1 and anti–
NH2-terminal LSP1, respectively, were collected, pooled separately, and
used in Western blotting assays and immunofluorescence microscopy. As a
control, the anti-LSP1 serum was also absorbed against both GST-LSP1 fu-
sion proteins and used in Western blotting.
Freshly isolated mouse leukocytes and mouse primary lung endothelial
cells were used for Western blot and RT-PCR analysis. Whole cell lysates
were prepared from these cells using Laemmli buffer with 10%  -mercapto-
ethanol, 10  g/ml leupeptin, and 10  g/ml aprotinin. The proteins were
separated by electrophoresis in 10% SDS-polyacrylamide gels, transferred toJEM VOL. 201, February 7, 2005 417
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a PVDF Hybond-P transfer membrane (Amersham Biosciences), and blot-
ted using a specific polyclonal rabbit anti–mouse LSP1 serum (at 1:2,000 di-
lution) as described previously (6) or the anti–COOH-terminal LSP1 and
anti–NH2-terminal LSP1 as described before. After washing, the membrane
was incubated with a secondary, horseradish peroxidase–conjugated goat
anti–rabbit IgG and treated with enhanced chemiluminescence reagents
(ECL kit; Amersham Biosciences). The blotted bands were detected with
high performance autoradiography films from Amersham Biosciences. RT-
PCR was performed using total RNA (100 ng for each cell type) extracted
from freshly isolated leukocytes, mouse primary lung endothelial cells, and
LSP1 primer pair A1/A4 as described previously (4). The PCR products
were electrophoresed by agarose gel, stained with ethidium bromide, and
analyzed by high sensitivity Fluor-S Multimager MAX scanner (Bio-Rad
Laboratories) upon dark subtraction.
Immunofluorescence microscopy. All rinsing, incubation, and dilution
of antibodies was performed in basal buffer that contained 137 NaCl, 5
KCl, 1.1 Na2HPO4, 0.4 KH2PO4, 4 NaHCO3, 5.5 glucose, 4.15 PIPES di-
sodium salt, 2 EGTA, and 4.15 MgCl2 in mM, pH 7.2, at room tempera-
ture. Mouse lung primary endothelial cells grown on glass coverslips for 24 h
were fixed with 4% formalin, permeabilized with 0.1% Triton X-100, and
incubated with 10  g/ml glycine. Primary antibodies used were the anti–
COOH-terminal LSP1 and anti–NH2-terminal LSP1 as described before
for 30 min where the protein concentrations were both 0.4 mg/ml in the
two blotting solutions, or the original rabbit polyclonal anti-LSP1 serum (at
1:100 dilution). After rinsing three times with 0.1% Tween-20, the cover-
slips were incubated with Cy3-conjugated goat anti–rabbit IgG for 30 min.
After rinsing with basal buffer, the coverslips were mounted in 90% glyc-
erol. Observations were performed on an Olympus IX-70 fluorescence mi-
croscope (Olympus). Fluorescence images were captured using OpenLab
software (version 3.1.5; Improvision Inc.).
To determine whether human endothelial cells express LSP1, we iso-
lated and cultured HUVECs as described previously (46). Once the HU-
VECs were confluent, they were passaged onto fibronectin-coated glass
coverslips. After culture for 24–48 h, these HUVECs were stained as out-
lined before with 2.5  g/ml mouse anti–human LSP1 mAb (clone 16; BD
Biosciences) and goat anti–mouse IgG conjugated with Texas Red (Molec-
ular Probes). DAPI (4 ,6-diamidino-2-phenylindole, dihydrochloride; Mo-
lecular Probes) was used for nuclear staining. To confirm that endothelial
cells and not a contaminating cell type expressed LSP1, we dual labeled the
HUVECs with FITC-conjugated anti–human VE-cadherin (Bender Med-
systems) in combination with LSP1 staining. To assess the association of
LSP1 with the cytoskeleton, we labeled HUVECs with anti-LSP1 and phal-
loidin (Alexa Fluor conjugated; Molecular Probes).
Statistical analysis. The data are expressed as means   SEM. A Student’s t
test was applied to compare the statistical difference within two groups, and
analysis of variance was used for the comparison of the differences in more
than two groups. A p-value of  0.05 was considered statistically significant.
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